De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.

MLA

Reijnders, Margot R. F., et al. “De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.” American Journal of Human Genetics, vol. 102, no. 6, June 2018, pp. 1195–203. EBSCOhost, https://doi.org/10.1016/j.ajhg.2018.04.014.

APA

Reijnders, M. R. F., Miller, K. A., Alvi, M., Goos, J. A. C., Lees, M. M., de Burca, A., Henderson, A., Kraus, A., Mikat, B., de Vries, B. B. A., Isidor, B., Kerr, B., Marcelis, C., Schluth-Bolard, C., Deshpande, C., Ruivenkamp, C. A. L., Wieczorek, D., Baralle, D., Blair, E. M., … Wilkie, A. O. M. (2018). De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder. American Journal of Human Genetics, 102(6), 1195–1203. https://doi.org/10.1016/j.ajhg.2018.04.014

Chicago

Reijnders, Margot R F, Kerry A Miller, Mohsan Alvi, Jacqueline A C Goos, Melissa M Lees, Anna de Burca, Alex Henderson, et al. 2018. “De Novo and Inherited Loss-of-Function Variants in TLK2: Clinical and Genotype-Phenotype Evaluation of a Distinct Neurodevelopmental Disorder.” American Journal of Human Genetics 102 (6): 1195–1203. doi:10.1016/j.ajhg.2018.04.014.